Louisiana Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Health Daily.

Press releases published on October 19, 2026

32 minutes ago

Enlivex Announces Cost Reduction Plan to Focus Resources on Phase 2b Trial of Allocetra™ in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Indeterminate GlobeNewswire

44 minutes ago

Enable Injections Announces Approval in Japan for CirCLIQ® Injector based on enFuse® On-Body Delivery System

Indeterminate GlobeNewswire

an hour ago

ArriVent Announces Cancer Cell Publication Highlighting Firmonertinib in EGFR PACC-Mutant Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire

an hour ago

argenx to Present Phase 3 ALKIVIA Results in Autoimmune Myositis as a Late-Breaking Oral Presentation at ACR Convergence 2026

Indeterminate GlobeNewswire

an hour ago

Nyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026

Indeterminate GlobeNewswire

an hour ago

Nyxoah Annonce ses Résultats Préliminaires pour le Troisième Trimestre 2026 et Ajuste ses Prévisions de Chiffre d’Affaires pour 2026

Indeterminate GlobeNewswire

an hour ago

GuideAI Health Enters Clinical Study and Software Pilot Agreement with Boone Heart Institute

Indeterminate GlobeNewswire

an hour ago

Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS

Indeterminate GlobeNewswire

an hour ago

Baird Medical Announces Regulatory Milestones in Vietnam and Egypt, Expanding International Reach of Microwave Ablation Technology

Indeterminate GlobeNewswire

an hour ago

SpyGlass Pharma Announces Positive 4-Year Data From First-in-Human Trial of Its Innovative BIM-IOL System

Indeterminate GlobeNewswire

an hour ago

UroGen Announces FDA Acceptance of the New Drug Application for UGN-103, an Investigational Treatment for Adults with Recurrent LG-IR-NMIBC

Indeterminate GlobeNewswire

an hour ago

Calidi Biotherapeutics to Present New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026

Indeterminate GlobeNewswire

an hour ago

Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors

Indeterminate GlobeNewswire

an hour ago

Phathom Pharmaceuticals to Report Third Quarter 2026 Financial Results and Provide Business Update on Thursday, October 29, 2026

Indeterminate GlobeNewswire

an hour ago

Milestone Pharmaceuticals Announces Clinical Data Presentations at Upcoming Cardiology Conferences

Indeterminate GlobeNewswire

an hour ago

ORIC® Pharmaceuticals to Host Conference Call & Webcast to Review Enozertinib Data Being Presented at ESMO Congress 2026

Indeterminate GlobeNewswire

an hour ago

Syncromune to Present Updated Long-Term Overall Survival Data from Phase 1 Trial of SYNC-T Therapy SV-102 in Metastatic Prostate Cancer at ESMO Congress 2026

Indeterminate GlobeNewswire

an hour ago

Rivus Pharmaceuticals to Present Preclinical Obesity Data for Muscle-Preserving, Oral GLP-1 RV-8451 at ObesityWeek®

Indeterminate GlobeNewswire

an hour ago

Altimmune to Present New Data on Pemvidutide in Serious Liver Diseases at AASLD The Liver Meeting® 2026

Indeterminate GlobeNewswire

an hour ago

BioVie Presents Data on Bezisterim in Long COVID at the 2026 American Neurological Association Annual Meeting

Indeterminate GlobeNewswire